Your Strategic Korea Market Advisory in Zurich

Entering the South Korean healthcare market is not primarily a language challenge. It is a challenge of interpretation. While AI tools can translate text, they often fail to bridge the "Logic Gap" in technical data and institutional decision-making.

Arirang Insight provides Swiss MedTech and healthcare executives with focused, human-led oversight. We fill the critical precision gap, ensuring that your strategy, data, and communication meet the rigorous standards of the Korean medical ecosystem.

Advisory Services

All services are delivered as standardised, fixed-scope modules to ensure analytical depth and operational efficiency.

1. Strategic Audit — The Human Filter

AI can translate words, but it cannot translate intent—and it often hallucinates technical data. A single statistical error, misplaced decimal point, or culturally tone-deaf expression can lead to regulatory rejection or a collapse in trust. Arirang Insight provides an independent second opinion to ensure your materials are ready for the Korean market.

• Focus: Meticulous proofreading of statistical data, technical terminology, and business context.

• Value: Providing a "High-Value Filter" that local branches or AI tools miss, ensuring data integrity before formal engagement.

• Deliverable: A concise Risk & Alignment Report (2–3 pages) with actionable "Red-pen" corrections.

• Standard: Review of materials (up to 10 pages) with a defined turnaround.

2. Market & Price Intelligence — The Insider Advantage

Surface-level data in English is often outdated or incomplete. We provide deep-dive insights utilizing Korean-language sources—government gazettes, specialist forums, and insider news—that are inaccessible to outsiders or automated tools.

• Focus: Real-world end-user pricing, current reimbursement (수가) structures, and upcoming policy shifts.

• Value: Capturing local stakeholder sentiment (clinicians/consumers) and price forecasts that determine your ROI.

• Deliverable: A Decision-Ready Briefing (2–4 pages) summarizing high-impact data and forecasts.

• Standard: Targeted analysis based on predefined topics (no open-ended research).

3. Field Intelligence — Remote Executive Presence

Stay ahead of the competition without the cost of travel. We translate the "noise" of the Korean medical scene into structured briefings, identifying strategic signals that global news outlets and AI summaries overlook.

• Focus: Direct observations from major events (e.g., KIMES) and competitor marketing tactics on the floor.

• Value: A "View from the Floor" that connects Korean medical innovation to your Swiss strategic goals.

• Deliverable: A structured Executive Summary (3–5 pages) with trend analysis and field feedback.

• Standard: Available for selected events only. Limited scope.

Who We Are

Arirang Insight is an independent Korea market advisory based in Zurich, supporting Swiss MedTech and healthcare companies with structured, fact-based insight.

• Independent perspective
  We provide objective, third-party review focused on HQ-level decision-making — without local bias.

• Zurich-based
  Aligned with Swiss working style, communication standards, and time zone.

• Attention to detail
  We identify small inconsistencies in data, terminology, and positioning that can lead to delays or misalignment in the Korean context.

Led by a PhD with experience across Swiss MedTech environments and Korean healthcare contexts, Arirang Insight focuses on clarity, accuracy, and practical decision support.